Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, Maeda M, Yoshioka T
Department of Radiology, Nara Medical University, Japan.
Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):140-5. doi: 10.1007/BF02575465.
Transcatheter hepatic segmental arterial chemoembolization using Lipiodol mixed with an anticancer drug followed by the injection of Gelfoam particles, introduced into the tumor-bearing hepatic segment as the target area (segmental Lipiodol-TAE), was carried out in 54 patients with hepatocellular carcinoma (HCC), 7 of whom were later resected. In 5 of the resected 7 cases, complete necrosis was histologically verified. No death due to HCC was encountered in 47 nonoperated cases, and better therapeutic results were obtained with segmental Lipiodol-TAE. It was concluded that this technique does not adversely affect normal tissues, and it does reinforce the effect of TAE.
对54例肝细胞癌（HCC）患者进行了经导管肝段动脉化疗栓塞术，方法是将碘油与抗癌药物混合，随后注入明胶海绵颗粒，将其引入作为靶区的荷瘤肝段（肝段碘油 - TAE），其中7例患者后来接受了手术切除。在切除的7例病例中的5例中，组织学证实有完全坏死。47例未手术的病例中未出现因肝癌导致的死亡，肝段碘油 - TAE取得了更好的治疗效果。得出的结论是，该技术不会对正常组织产生不利影响，并且确实增强了TAE的效果。
